Explainable AI with human validation enables faster, transparent adverse event detection, strengthening clinical workflows and ensuring confident, defensible safety decisions at scale. Read More
Author Archives: Santosh Shevade
Improving Clinical Data Quality: From Manual Reporting to Intelligent Automation
AI-driven reporting improves clinical data quality by reducing manual effort and enabling faster, reliable insights for research and Read More
Pharma Labeling Transformation: SCMS and the Road to Digital Compliance
Organizations that connect regulatory monitoring, structured content management, and digital artwork workflows will be better prepared to stay compliant and respond quickly to change. Read More
Optimizing Modular Content Creation for Pharma Teams
Pharma’s reliance on long-form documents and manual versioning cannot keep pace with global complexity. Read More
AI-Powered Translation and Localization in Pharma Content Operations
AI-powered translation—guided by structured content and domain expertise, offers a practical and sustainable path forward. Read More
How AI in Clinical Data Analysis Is Shaping Scientific Narratives
How AI in clinical data analysis helps pharma teams transform trial data into clear, compliant, and compelling scientific narratives. Read More
How Data & AI are Making HCP Engagement Shockingly Personal
With Straive, personalization becomes more than a tech upgrade—it’s a cultural shift that builds stronger, more relevant HCP relationships. Read More
Why RWE Data Curation Needs a Domain-Led Approach
The actual value of RWE lies not just in the breadth of real-world data but also in its ability to curate it with precision, compliance, and contextual understanding. Read More
Breaking Down Data Silos: A Pathway to Enhanced Clinical Insights in Pharma
Straive helps break down pharma data silos for operational agility and better trial and regulatory outcomes. Straive enables this with advanced AI, governance, and integration solutions that unify data across the pharma value chain. Read More
Build vs. Buy in Pharma AI: Why Strategic Partnerships Surpass In-House Builds
Imagine a leading pharmaceutical team, eager to harness AI for drug discovery. Months are spent building an in-house solution, yet six months later, the pilot struggles to deliver results. Read More